Clinicians Face Challenges with Off-Label Retatrutide Use | Retatrutide News

Clinicians are facing challenges with the off-label use of Retatrutide, a GLP-1 receptor agonist. This situation underscores the need for careful regula...
Market News · November 5, 2026